Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(-kappa)B transcription factors.

van Heel DA, Udalova IA, De Silva AP, McGovern DP, Kinouchi Y, Hull J, Lench NJ, Cardon LR, Carey AH, Jewell DP, Kwiatkowski D.

Hum Mol Genet. 2002 May 15;11(11):1281-9.

PMID:
12019209
2.

[NF-kappa B and inflammatory intestinal diseases].

Nosti-Escanilla MP, Peña AS.

Rev Esp Enferm Dig. 1998 Feb;90(2):113-9. Review. Spanish.

PMID:
9580438
3.

Glucocorticoid resistance in inflammatory bowel disease.

Farrell RJ, Kelleher D.

J Endocrinol. 2003 Sep;178(3):339-46. Review.

4.

Pharmacogenomics of response to anti-tumor necrosis factor therapy in patients with Crohn's disease.

Shetty A, Forbes A.

Am J Pharmacogenomics. 2002;2(4):215-21. Review.

PMID:
12421092
5.

NF-kappaB in inflammatory bowel disease.

Atreya I, Atreya R, Neurath MF.

J Intern Med. 2008 Jun;263(6):591-6. doi: 10.1111/j.1365-2796.2008.01953.x. Review.

6.

Tumor necrosis factor (TNF) in inflammatory bowel disease: gene polymorphisms, animal models, and potential for anti-TNF therapy.

Stokkers PC, Camoglio L, van Deventer SJ.

J Inflamm. 1995-1996;47(1-2):97-103. Review.

PMID:
8913936

Supplemental Content

Support Center